Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2013 Feb;162(2):349-56.
doi: 10.1016/j.jpeds.2012.07.043. Epub 2012 Aug 30.

Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children

Affiliations
Randomized Controlled Trial

Randomized double-blind controlled trial of bovine lactoferrin for prevention of diarrhea in children

Theresa J Ochoa et al. J Pediatr. 2013 Feb.

Abstract

Objective: To determine the effect of bovine lactoferrin (bLF) on prevention of diarrhea in children.

Study design: We conducted a community-based randomized double-blind placebo controlled trial comparing supplementation with bLF vs placebo. Previously weaned children were enrolled at 12-18 months and followed for 6 months with daily home visits for data collection and supplement administration. Anthropometric measures were done monthly.

Results: Five hundred fifty-five children were randomized: 277 to bLF and 278 to placebo; 65 dropped out; 147 894 doses were administered (92% compliance). Overall there were 91 446 child-days of observation and 1235 diarrhea episodes lasting 6219 days. The main pathogens isolated during diarrheal episodes were norovirus (35.0%), enteropathogenic E coli (11.4%), Campylobacter (10.6%), enteroaggregative E coli (8.4%), enterotoxigenic E coli (6.9%), and Shigella (6.6%). The diarrhea incidence was not different between groups: 5.4 vs 5.2 episodes/child/year for bLF and placebo, respectively (P = .375). However, the diarrhea longitudinal prevalence was lower in the bLF group vs placebo (6.6% vs 7.0%, P = .017), as well as the median duration of episodes (4.8 vs 5.3 days, P = .046), proportion of episodes with moderate or severe dehydration (1.0% vs 2.6%, P = .045), and liquid stools load (95.0 vs 98.6) liquid stools/child/year, P < .001). There were no adverse events related to the intervention.

Conclusions: Although there was no decrease in diarrhea incidence, longitudinal prevalence and severity were decreased with LF.

Trial registration: ClinicalTrials.gov NCT00560222.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

Figures

Figure 1
Figure 1
Study flow diagram. Enrollment: 3,674 children were assessed for eligibility. Allocation: 277 were randomized to lactoferrin and 278 to placebo; all received the allocated intervention. Follow-up: there were 25 and 40 drop-outs in the lactoferrin and placebo groups respectively. None were excluded from the analysis.

References

    1. Black RE, Cousens S, Johnson HL, Lawn JE, Rudan I, Bassani DG, et al. Global, regional, and national causes of child mortality in 2008: a systematic analysis. Lancet. 2010;375:1969–1987. - PubMed
    1. Guerrant RL, Oriá RB, Moore SR, Oriá MO, Lima AA. Malnutrition as an enteric infectious disease with long-term effects on child development. Nutr Rev. 2008;66:487–505. - PMC - PubMed
    1. Jones G, Steketee RW, Black RE, Bhutta ZA, Morris SS Bellagio Child Survival Study Group. How many child deaths can we prevent this year? Lancet. 2003;362:65–71. - PubMed
    1. Victora CG, Smith PG, Vaughan JP, Nobre LC, Lombardi C, Teixeira AM, et al. Infant feeding and deaths due to diarrhea. A case-control study. Am J Epidemiol. 1989;129:1032–1041. - PubMed
    1. Morrow AL, Rangel JM. Human milk protection against infectious diarrhea: implications for prevention and clinical care. Semin Pediatr Infect Dis. 2004;15:221–228. - PubMed

Publication types

Associated data